<DOC>
	<DOC>NCT02600273</DOC>
	<brief_summary>The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.</brief_summary>
	<brief_title>Novel Approaches to Reducing Tobacco Related Harm</brief_title>
	<detailed_description>Participants will sample 4 alternative nicotine/tobacco products and provide initial reactions to the products.</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>1. HIVinfected adults age 18 and older currently receiving HIV care 2. Selfreport smoking ≥10 cigarettes/day of a brand delivering &gt;0.5mg nicotine for &gt;2yrs 3. Have afternoon expired CO concentrations of ≥10ppm or morning urinary cotinine &gt;100ng/ml (as measured with NicAlert) 1. Impaired mental status as assessed by observation 2. Acute intoxication as measured by breath alcohol level (BAL) &gt; 0 3. Current use of nicotine replacement or other pharmacotherapy for smoking cessation 4. Previous use of ecigarettes 5. Use of other tobacco products (e.g., chew tobacco, cigars) on &gt; 10 of the past 30 days 6. Unstable HIV or associated comorbidities, as determined by a licensed medical professional. 7. Pregnancy (Females testing positive for pregnancy and any participants wishing to quit immediately will be referred to community smoking cessation treatment and will be excluded from the study) 8. Blood pressure at or above 160/100 or below 90/50 9. Heart rate at or above 105 bpm or below 45 bpm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>